糖尿病性眼疾患治療のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Diabetes Associated Ophthalmic Treatment Market Insights, Forecast to 2028

• レポートコード：QY2207C3487 • 出版社/出版日：QYResearch / 2022年7月11日 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の糖尿病性眼疾患治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に糖尿病性眼疾患治療の世界市場のxxx％を占める「ドライアイ症候群」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の糖尿病性眼疾患治療の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの糖尿病性眼疾患治療市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの糖尿病性眼疾患治療市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 糖尿病性眼疾患治療のグローバル主要メーカーには、Alcon、Johnson & Johnson Services, Inc.、Bausch Health、F. Hoffmann-La Roche Ltd、Allergan、Bayer AG、Santen Pharmaceutical Co. Ltd.、Novartis AG、Pfizer, Inc.、Genentech, Inc.、Carl Zeiss Meditec、Lumenis、Ellex Medical Lasers Ltd.、IRIDEX Corp.、Topcon Corp.、Abbott Medical Optics、Quantelなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 糖尿病性眼疾患治療市場は、種類と用途によって区分されます。世界の糖尿病性眼疾患治療市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 ドライアイ症候群、緑内障、眼アレルギー＆感染症、糖尿病性網膜症、糖尿病性黄斑変性症、ブドウ膜炎、白内障、糖尿病性黄斑浮腫、その他 【用途別セグメント】 病院、眼科センター、外来外科センター、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 糖尿病性眼疾患治療製品概要 - 種類別市場（ドライアイ症候群、緑内障、眼アレルギー＆感染症、糖尿病性網膜症、糖尿病性黄斑変性症、ブドウ膜炎、白内障、糖尿病性黄斑浮腫、その他） - 用途別市場（病院、眼科センター、外来外科センター、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の糖尿病性眼疾患治療販売量予測2017-2028 - 世界の糖尿病性眼疾患治療売上予測2017-2028 - 糖尿病性眼疾患治療の地域別販売量 - 糖尿病性眼疾患治療の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別糖尿病性眼疾患治療販売量 - 主要メーカー別糖尿病性眼疾患治療売上 - 主要メーカー別糖尿病性眼疾患治療価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（ドライアイ症候群、緑内障、眼アレルギー＆感染症、糖尿病性網膜症、糖尿病性黄斑変性症、ブドウ膜炎、白内障、糖尿病性黄斑浮腫、その他） - 糖尿病性眼疾患治療の種類別販売量 - 糖尿病性眼疾患治療の種類別売上 - 糖尿病性眼疾患治療の種類別価格 ・用途別市場規模（病院、眼科センター、外来外科センター、その他） - 糖尿病性眼疾患治療の用途別販売量 - 糖尿病性眼疾患治療の用途別売上 - 糖尿病性眼疾患治療の用途別価格 ・北米市場 - 北米の糖尿病性眼疾患治療市場規模（種類別、用途別） - 主要国別の糖尿病性眼疾患治療市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの糖尿病性眼疾患治療市場規模（種類別、用途別） - 主要国別の糖尿病性眼疾患治療市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の糖尿病性眼疾患治療市場規模（種類別、用途別） - 主要国別の糖尿病性眼疾患治療市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の糖尿病性眼疾患治療市場規模（種類別、用途別） - 主要国別の糖尿病性眼疾患治療市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの糖尿病性眼疾患治療市場規模（種類別、用途別） - 主要国別の糖尿病性眼疾患治療市場規模（トルコ、サウジアラビア） ・企業情報 Alcon、Johnson & Johnson Services, Inc.、Bausch Health、F. Hoffmann-La Roche Ltd、Allergan、Bayer AG、Santen Pharmaceutical Co. Ltd.、Novartis AG、Pfizer, Inc.、Genentech, Inc.、Carl Zeiss Meditec、Lumenis、Ellex Medical Lasers Ltd.、IRIDEX Corp.、Topcon Corp.、Abbott Medical Optics、Quantel ・産業チェーン及び販売チャネル分析 - 糖尿病性眼疾患治療の産業チェーン分析 - 糖尿病性眼疾患治療の原材料 - 糖尿病性眼疾患治療の生産プロセス - 糖尿病性眼疾患治療の販売及びマーケティング - 糖尿病性眼疾患治療の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 糖尿病性眼疾患治療の産業動向 - 糖尿病性眼疾患治療のマーケットドライバー - 糖尿病性眼疾患治療の課題 - 糖尿病性眼疾患治療の阻害要因 ・主な調査結果

Diabetic eye disease is a group of eye problems that can affect people with diabetes. These conditions include diabetic retinopathy, diabetic macular edema, cataracts, and glaucoma. An increase in the incidence of diabetes due to aging, obesity, and an unhealthy lifestyle is one of the factors contributing to the growth of the market for diabetes-associated ophthalmic.
Market Analysis and Insights: Global Diabetes Associated Ophthalmic Treatment Market
The global Diabetes Associated Ophthalmic Treatment market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Dry Eye Syndrome accounting for % of the Diabetes Associated Ophthalmic Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Diabetes Associated Ophthalmic Treatment market size is valued at US$ million in 2021, while the North America and Europe Diabetes Associated Ophthalmic Treatment are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Diabetes Associated Ophthalmic Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Diabetes Associated Ophthalmic Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Diabetes Associated Ophthalmic Treatment market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Diabetes Associated Ophthalmic Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Diabetes Associated Ophthalmic Treatment market.
Global Diabetes Associated Ophthalmic Treatment Scope and Market Size
Diabetes Associated Ophthalmic Treatment market is segmented by players, region (country), by Type and by End User. Players, stakeholders, and other participants in the global Diabetes Associated Ophthalmic Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by End User for the period 2017-2028.
Segment by Type
Dry Eye Syndrome
Glaucoma
Eye Allergy & Infection
Diabetic Retinopathy
Diabetic associated Macular Degeneration
Uveitis
Cataract
Diabetic Macular Edema
Others
Segment by End User
Hospitals
Ophthalmic Centers
Ambulatory Surgical Centers
Others
By Company
Alcon
Johnson & Johnson Services, Inc.
Bausch Health
F. Hoffmann-La Roche Ltd
Allergan
Bayer AG
Santen Pharmaceutical Co. Ltd.
Novartis AG
Pfizer, Inc.
Genentech, Inc.
Carl Zeiss Meditec
Lumenis
Ellex Medical Lasers Ltd.
IRIDEX Corp.
Topcon Corp.
Abbott Medical Optics
Quantel
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

---

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetes Associated Ophthalmic Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Dry Eye Syndrome
1.2.3 Glaucoma
1.2.4 Eye Allergy & Infection
1.2.5 Diabetic Retinopathy
1.2.6 Diabetic associated Macular Degeneration
1.2.7 Uveitis
1.2.8 Cataract
1.2.9 Diabetic Macular Edema
1.2.10 Others
1.3 Market by End User
1.3.1 Global Diabetes Associated Ophthalmic Treatment Market Size Growth Rate by End User, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Ophthalmic Centers
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Diabetes Associated Ophthalmic Treatment Market Perspective (2017-2028)
2.2 Diabetes Associated Ophthalmic Treatment Growth Trends by Region
2.2.1 Diabetes Associated Ophthalmic Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Diabetes Associated Ophthalmic Treatment Historic Market Size by Region (2017-2022)
2.2.3 Diabetes Associated Ophthalmic Treatment Forecasted Market Size by Region (2023-2028)
2.3 Diabetes Associated Ophthalmic Treatment Market Dynamics
2.3.1 Diabetes Associated Ophthalmic Treatment Industry Trends
2.3.2 Diabetes Associated Ophthalmic Treatment Market Drivers
2.3.3 Diabetes Associated Ophthalmic Treatment Market Challenges
2.3.4 Diabetes Associated Ophthalmic Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diabetes Associated Ophthalmic Treatment Players by Revenue
3.1.1 Global Top Diabetes Associated Ophthalmic Treatment Players by Revenue (2017-2022)
3.1.2 Global Diabetes Associated Ophthalmic Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Diabetes Associated Ophthalmic Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Diabetes Associated Ophthalmic Treatment Revenue
3.4 Global Diabetes Associated Ophthalmic Treatment Market Concentration Ratio
3.4.1 Global Diabetes Associated Ophthalmic Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetes Associated Ophthalmic Treatment Revenue in 2021
3.5 Diabetes Associated Ophthalmic Treatment Key Players Head office and Area Served
3.6 Key Players Diabetes Associated Ophthalmic Treatment Product Solution and Service
3.7 Date of Enter into Diabetes Associated Ophthalmic Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetes Associated Ophthalmic Treatment Breakdown Data by Type
4.1 Global Diabetes Associated Ophthalmic Treatment Historic Market Size by Type (2017-2022)
4.2 Global Diabetes Associated Ophthalmic Treatment Forecasted Market Size by Type (2023-2028)
5 Diabetes Associated Ophthalmic Treatment Breakdown Data by End User
5.1 Global Diabetes Associated Ophthalmic Treatment Historic Market Size by End User (2017-2022)
5.2 Global Diabetes Associated Ophthalmic Treatment Forecasted Market Size by End User (2023-2028)
6 North America
6.1 North America Diabetes Associated Ophthalmic Treatment Market Size (2017-2028)
6.2 North America Diabetes Associated Ophthalmic Treatment Market Size by Type
6.2.1 North America Diabetes Associated Ophthalmic Treatment Market Size by Type (2017-2022)
6.2.2 North America Diabetes Associated Ophthalmic Treatment Market Size by Type (2023-2028)
6.2.3 North America Diabetes Associated Ophthalmic Treatment Market Share by Type (2017-2028)
6.3 North America Diabetes Associated Ophthalmic Treatment Market Size by End User
6.3.1 North America Diabetes Associated Ophthalmic Treatment Market Size by End User (2017-2022)
6.3.2 North America Diabetes Associated Ophthalmic Treatment Market Size by End User (2023-2028)
6.3.3 North America Diabetes Associated Ophthalmic Treatment Market Share by End User (2017-2028)
6.4 North America Diabetes Associated Ophthalmic Treatment Market Size by Country
6.4.1 North America Diabetes Associated Ophthalmic Treatment Market Size by Country (2017-2022)
6.4.2 North America Diabetes Associated Ophthalmic Treatment Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Diabetes Associated Ophthalmic Treatment Market Size (2017-2028)
7.2 Europe Diabetes Associated Ophthalmic Treatment Market Size by Type
7.2.1 Europe Diabetes Associated Ophthalmic Treatment Market Size by Type (2017-2022)
7.2.2 Europe Diabetes Associated Ophthalmic Treatment Market Size by Type (2023-2028)
7.2.3 Europe Diabetes Associated Ophthalmic Treatment Market Share by Type (2017-2028)
7.3 Europe Diabetes Associated Ophthalmic Treatment Market Size by End User
7.3.1 Europe Diabetes Associated Ophthalmic Treatment Market Size by End User (2017-2022)
7.3.2 Europe Diabetes Associated Ophthalmic Treatment Market Size by End User (2023-2028)
7.3.3 Europe Diabetes Associated Ophthalmic Treatment Market Share by End User (2017-2028)
7.4 Europe Diabetes Associated Ophthalmic Treatment Market Size by Country
7.4.1 Europe Diabetes Associated Ophthalmic Treatment Market Size by Country (2017-2022)
7.4.2 Europe Diabetes Associated Ophthalmic Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Diabetes Associated Ophthalmic Treatment Market Size (2017-2028)
8.2 Asia-Pacific Diabetes Associated Ophthalmic Treatment Market Size by Type
8.2.1 Asia-Pacific Diabetes Associated Ophthalmic Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Diabetes Associated Ophthalmic Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Diabetes Associated Ophthalmic Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Diabetes Associated Ophthalmic Treatment Market Size by End User
8.3.1 Asia-Pacific Diabetes Associated Ophthalmic Treatment Market Size by End User (2017-2022)
8.3.2 Asia-Pacific Diabetes Associated Ophthalmic Treatment Market Size by End User (2023-2028)
8.3.3 Asia-Pacific Diabetes Associated Ophthalmic Treatment Market Share by End User (2017-2028)
8.4 Asia-Pacific Diabetes Associated Ophthalmic Treatment Market Size by Region
8.4.1 Asia-Pacific Diabetes Associated Ophthalmic Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Diabetes Associated Ophthalmic Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Diabetes Associated Ophthalmic Treatment Market Size (2017-2028)
9.2 Latin America Diabetes Associated Ophthalmic Treatment Market Size by Type
9.2.1 Latin America Diabetes Associated Ophthalmic Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Diabetes Associated Ophthalmic Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Diabetes Associated Ophthalmic Treatment Market Share by Type (2017-2028)
9.3 Latin America Diabetes Associated Ophthalmic Treatment Market Size by End User
9.3.1 Latin America Diabetes Associated Ophthalmic Treatment Market Size by End User (2017-2022)
9.3.2 Latin America Diabetes Associated Ophthalmic Treatment Market Size by End User (2023-2028)
9.3.3 Latin America Diabetes Associated Ophthalmic Treatment Market Share by End User (2017-2028)
9.4 Latin America Diabetes Associated Ophthalmic Treatment Market Size by Country
9.4.1 Latin America Diabetes Associated Ophthalmic Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Diabetes Associated Ophthalmic Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diabetes Associated Ophthalmic Treatment Market Size (2017-2028)
10.2 Middle East & Africa Diabetes Associated Ophthalmic Treatment Market Size by Type
10.2.1 Middle East & Africa Diabetes Associated Ophthalmic Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Diabetes Associated Ophthalmic Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Diabetes Associated Ophthalmic Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Diabetes Associated Ophthalmic Treatment Market Size by End User
10.3.1 Middle East & Africa Diabetes Associated Ophthalmic Treatment Market Size by End User (2017-2022)
10.3.2 Middle East & Africa Diabetes Associated Ophthalmic Treatment Market Size by End User (2023-2028)
10.3.3 Middle East & Africa Diabetes Associated Ophthalmic Treatment Market Share by End User (2017-2028)
10.4 Middle East & Africa Diabetes Associated Ophthalmic Treatment Market Size by Country
10.4.1 Middle East & Africa Diabetes Associated Ophthalmic Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Diabetes Associated Ophthalmic Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Alcon
11.1.1 Alcon Company Details
11.1.2 Alcon Business Overview
11.1.3 Alcon Diabetes Associated Ophthalmic Treatment Introduction
11.1.4 Alcon Revenue in Diabetes Associated Ophthalmic Treatment Business (2017-2022)
11.1.5 Alcon Recent Developments
11.2 Johnson & Johnson Services, Inc.
11.2.1 Johnson & Johnson Services, Inc. Company Details
11.2.2 Johnson & Johnson Services, Inc. Business Overview
11.2.3 Johnson & Johnson Services, Inc. Diabetes Associated Ophthalmic Treatment Introduction
11.2.4 Johnson & Johnson Services, Inc. Revenue in Diabetes Associated Ophthalmic Treatment Business (2017-2022)
11.2.5 Johnson & Johnson Services, Inc. Recent Developments
11.3 Bausch Health
11.3.1 Bausch Health Company Details
11.3.2 Bausch Health Business Overview
11.3.3 Bausch Health Diabetes Associated Ophthalmic Treatment Introduction
11.3.4 Bausch Health Revenue in Diabetes Associated Ophthalmic Treatment Business (2017-2022)
11.3.5 Bausch Health Recent Developments
11.4 F. Hoffmann-La Roche Ltd
11.4.1 F. Hoffmann-La Roche Ltd Company Details
11.4.2 F. Hoffmann-La Roche Ltd Business Overview
11.4.3 F. Hoffmann-La Roche Ltd Diabetes Associated Ophthalmic Treatment Introduction
11.4.4 F. Hoffmann-La Roche Ltd Revenue in Diabetes Associated Ophthalmic Treatment Business (2017-2022)
11.4.5 F. Hoffmann-La Roche Ltd Recent Developments
11.5 Allergan
11.5.1 Allergan Company Details
11.5.2 Allergan Business Overview
11.5.3 Allergan Diabetes Associated Ophthalmic Treatment Introduction
11.5.4 Allergan Revenue in Diabetes Associated Ophthalmic Treatment Business (2017-2022)
11.5.5 Allergan Recent Developments
11.6 Bayer AG
11.6.1 Bayer AG Company Details
11.6.2 Bayer AG Business Overview
11.6.3 Bayer AG Diabetes Associated Ophthalmic Treatment Introduction
11.6.4 Bayer AG Revenue in Diabetes Associated Ophthalmic Treatment Business (2017-2022)
11.6.5 Bayer AG Recent Developments
11.7 Santen Pharmaceutical Co. Ltd.
11.7.1 Santen Pharmaceutical Co. Ltd. Company Details
11.7.2 Santen Pharmaceutical Co. Ltd. Business Overview
11.7.3 Santen Pharmaceutical Co. Ltd. Diabetes Associated Ophthalmic Treatment Introduction
11.7.4 Santen Pharmaceutical Co. Ltd. Revenue in Diabetes Associated Ophthalmic Treatment Business (2017-2022)
11.7.5 Santen Pharmaceutical Co. Ltd. Recent Developments
11.8 Novartis AG
11.8.1 Novartis AG Company Details
11.8.2 Novartis AG Business Overview
11.8.3 Novartis AG Diabetes Associated Ophthalmic Treatment Introduction
11.8.4 Novartis AG Revenue in Diabetes Associated Ophthalmic Treatment Business (2017-2022)
11.8.5 Novartis AG Recent Developments
11.9 Pfizer, Inc.
11.9.1 Pfizer, Inc. Company Details
11.9.2 Pfizer, Inc. Business Overview
11.9.3 Pfizer, Inc. Diabetes Associated Ophthalmic Treatment Introduction
11.9.4 Pfizer, Inc. Revenue in Diabetes Associated Ophthalmic Treatment Business (2017-2022)
11.9.5 Pfizer, Inc. Recent Developments
11.10 Genentech, Inc.
11.10.1 Genentech, Inc. Company Details
11.10.2 Genentech, Inc. Business Overview
11.10.3 Genentech, Inc. Diabetes Associated Ophthalmic Treatment Introduction
11.10.4 Genentech, Inc. Revenue in Diabetes Associated Ophthalmic Treatment Business (2017-2022)
11.10.5 Genentech, Inc. Recent Developments
11.11 Carl Zeiss Meditec
11.11.1 Carl Zeiss Meditec Company Details
11.11.2 Carl Zeiss Meditec Business Overview
11.11.3 Carl Zeiss Meditec Diabetes Associated Ophthalmic Treatment Introduction
11.11.4 Carl Zeiss Meditec Revenue in Diabetes Associated Ophthalmic Treatment Business (2017-2022)
11.11.5 Carl Zeiss Meditec Recent Developments
11.12 Lumenis
11.12.1 Lumenis Company Details
11.12.2 Lumenis Business Overview
11.12.3 Lumenis Diabetes Associated Ophthalmic Treatment Introduction
11.12.4 Lumenis Revenue in Diabetes Associated Ophthalmic Treatment Business (2017-2022)
11.12.5 Lumenis Recent Developments
11.13 Ellex Medical Lasers Ltd.
11.13.1 Ellex Medical Lasers Ltd. Company Details
11.13.2 Ellex Medical Lasers Ltd. Business Overview
11.13.3 Ellex Medical Lasers Ltd. Diabetes Associated Ophthalmic Treatment Introduction
11.13.4 Ellex Medical Lasers Ltd. Revenue in Diabetes Associated Ophthalmic Treatment Business (2017-2022)
11.13.5 Ellex Medical Lasers Ltd. Recent Developments
11.14 IRIDEX Corp.
11.14.1 IRIDEX Corp. Company Details
11.14.2 IRIDEX Corp. Business Overview
11.14.3 IRIDEX Corp. Diabetes Associated Ophthalmic Treatment Introduction
11.14.4 IRIDEX Corp. Revenue in Diabetes Associated Ophthalmic Treatment Business (2017-2022)
11.14.5 IRIDEX Corp. Recent Developments
11.15 Topcon Corp.
11.15.1 Topcon Corp. Company Details
11.15.2 Topcon Corp. Business Overview
11.15.3 Topcon Corp. Diabetes Associated Ophthalmic Treatment Introduction
11.15.4 Topcon Corp. Revenue in Diabetes Associated Ophthalmic Treatment Business (2017-2022)
11.15.5 Topcon Corp. Recent Developments
11.16 Abbott Medical Optics
11.16.1 Abbott Medical Optics Company Details
11.16.2 Abbott Medical Optics Business Overview
11.16.3 Abbott Medical Optics Diabetes Associated Ophthalmic Treatment Introduction
11.16.4 Abbott Medical Optics Revenue in Diabetes Associated Ophthalmic Treatment Business (2017-2022)
11.16.5 Abbott Medical Optics Recent Developments
11.17 Quantel
11.17.1 Quantel Company Details
11.17.2 Quantel Business Overview
11.17.3 Quantel Diabetes Associated Ophthalmic Treatment Introduction
11.17.4 Quantel Revenue in Diabetes Associated Ophthalmic Treatment Business (2017-2022)
11.17.5 Quantel Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Diabetes Associated Ophthalmic Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Dry Eye Syndrome
Table 3. Key Players of Glaucoma
Table 4. Key Players of Eye Allergy & Infection
Table 5. Key Players of Diabetic Retinopathy
Table 6. Key Players of Diabetic associated Macular Degeneration
Table 7. Key Players of Uveitis
Table 8. Key Players of Cataract
Table 9. Key Players of Diabetic Macular Edema
Table 10. Key Players of Others
Table 11. Global Diabetes Associated Ophthalmic Treatment Market Size Growth Rate by End User (US$ Million), 2017 VS 2021 VS 2028
Table 12. Global Diabetes Associated Ophthalmic Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 13. Global Diabetes Associated Ophthalmic Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 14. Global Diabetes Associated Ophthalmic Treatment Market Share by Region (2017-2022)
Table 15. Global Diabetes Associated Ophthalmic Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 16. Global Diabetes Associated Ophthalmic Treatment Market Share by Region (2023-2028)
Table 17. Diabetes Associated Ophthalmic Treatment Market Trends
Table 18. Diabetes Associated Ophthalmic Treatment Market Drivers
Table 19. Diabetes Associated Ophthalmic Treatment Market Challenges
Table 20. Diabetes Associated Ophthalmic Treatment Market Restraints
Table 21. Global Diabetes Associated Ophthalmic Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 22. Global Diabetes Associated Ophthalmic Treatment Revenue Share by Players (2017-2022)
Table 23. Global Top Diabetes Associated Ophthalmic Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Associated Ophthalmic Treatment as of 2021)
Table 24. Ranking of Global Top Diabetes Associated Ophthalmic Treatment Companies by Revenue (US$ Million) in 2021
Table 25. Global 5 Largest Players Market Share by Diabetes Associated Ophthalmic Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Diabetes Associated Ophthalmic Treatment Product Solution and Service
Table 28. Date of Enter into Diabetes Associated Ophthalmic Treatment Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Diabetes Associated Ophthalmic Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 31. Global Diabetes Associated Ophthalmic Treatment Revenue Market Share by Type (2017-2022)
Table 32. Global Diabetes Associated Ophthalmic Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 33. Global Diabetes Associated Ophthalmic Treatment Revenue Market Share by Type (2023-2028)
Table 34. Global Diabetes Associated Ophthalmic Treatment Market Size by End User (2017-2022) & (US$ Million)
Table 35. Global Diabetes Associated Ophthalmic Treatment Revenue Share by End User (2017-2022)
Table 36. Global Diabetes Associated Ophthalmic Treatment Forecasted Market Size by End User (2023-2028) & (US$ Million)
Table 37. Global Diabetes Associated Ophthalmic Treatment Revenue Share by End User (2023-2028)
Table 38. North America Diabetes Associated Ophthalmic Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 39. North America Diabetes Associated Ophthalmic Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 40. North America Diabetes Associated Ophthalmic Treatment Market Size by End User (2017-2022) & (US$ Million)
Table 41. North America Diabetes Associated Ophthalmic Treatment Market Size by End User (2023-2028) & (US$ Million)
Table 42. North America Diabetes Associated Ophthalmic Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 43. North America Diabetes Associated Ophthalmic Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 44. Europe Diabetes Associated Ophthalmic Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 45. Europe Diabetes Associated Ophthalmic Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 46. Europe Diabetes Associated Ophthalmic Treatment Market Size by End User (2017-2022) & (US$ Million)
Table 47. Europe Diabetes Associated Ophthalmic Treatment Market Size by End User (2023-2028) & (US$ Million)
Table 48. Europe Diabetes Associated Ophthalmic Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 49. Europe Diabetes Associated Ophthalmic Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 50. Asia Pacific Diabetes Associated Ophthalmic Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 51. Asia Pacific Diabetes Associated Ophthalmic Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 52. Asia Pacific Diabetes Associated Ophthalmic Treatment Market Size by End User (2017-2022) & (US$ Million)
Table 53. Asia Pacific Diabetes Associated Ophthalmic Treatment Market Size by End User (2023-2028) & (US$ Million)
Table 54. Asia Pacific Diabetes Associated Ophthalmic Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 55. Asia Pacific Diabetes Associated Ophthalmic Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 56. Latin America Diabetes Associated Ophthalmic Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 57. Latin America Diabetes Associated Ophthalmic Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 58. Latin America Diabetes Associated Ophthalmic Treatment Market Size by End User (2017-2022) & (US$ Million)
Table 59. Latin America Diabetes Associated Ophthalmic Treatment Market Size by End User (2023-2028) & (US$ Million)
Table 60. Latin America Diabetes Associated Ophthalmic Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 61. Latin America Diabetes Associated Ophthalmic Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Diabetes Associated Ophthalmic Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Diabetes Associated Ophthalmic Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 64. Middle East and Africa Diabetes Associated Ophthalmic Treatment Market Size by End User (2017-2022) & (US$ Million)
Table 65. Middle East and Africa Diabetes Associated Ophthalmic Treatment Market Size by End User (2023-2028) & (US$ Million)
Table 66. Middle East and Africa Diabetes Associated Ophthalmic Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 67. Middle East and Africa Diabetes Associated Ophthalmic Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 68. Alcon Company Details
Table 69. Alcon Business Overview
Table 70. Alcon Diabetes Associated Ophthalmic Treatment Product
Table 71. Alcon Revenue in Diabetes Associated Ophthalmic Treatment Business (2017-2022) & (US$ Million)
Table 72. Alcon Recent Developments
Table 73. Johnson & Johnson Services, Inc. Company Details
Table 74. Johnson & Johnson Services, Inc. Business Overview
Table 75. Johnson & Johnson Services, Inc. Diabetes Associated Ophthalmic Treatment Product
Table 76. Johnson & Johnson Services, Inc. Revenue in Diabetes Associated Ophthalmic Treatment Business (2017-2022) & (US$ Million)
Table 77. Johnson & Johnson Services, Inc. Recent Developments
Table 78. Bausch Health Company Details
Table 79. Bausch Health Business Overview
Table 80. Bausch Health Diabetes Associated Ophthalmic Treatment Product
Table 81. Bausch Health Revenue in Diabetes Associated Ophthalmic Treatment Business (2017-2022) & (US$ Million)
Table 82. Bausch Health Recent Developments
Table 83. F. Hoffmann-La Roche Ltd Company Details
Table 84. F. Hoffmann-La Roche Ltd Business Overview
Table 85. F. Hoffmann-La Roche Ltd Diabetes Associated Ophthalmic Treatment Product
Table 86. F. Hoffmann-La Roche Ltd Revenue in Diabetes Associated Ophthalmic Treatment Business (2017-2022) & (US$ Million)
Table 87. F. Hoffmann-La Roche Ltd Recent Developments
Table 88. Allergan Company Details
Table 89. Allergan Business Overview
Table 90. Allergan Diabetes Associated Ophthalmic Treatment Product
Table 91. Allergan Revenue in Diabetes Associated Ophthalmic Treatment Business (2017-2022) & (US$ Million)
Table 92. Allergan Recent Developments
Table 93. Bayer AG Company Details
Table 94. Bayer AG Business Overview
Table 95. Bayer AG Diabetes Associated Ophthalmic Treatment Product
Table 96. Bayer AG Revenue in Diabetes Associated Ophthalmic Treatment Business (2017-2022) & (US$ Million)
Table 97. Bayer AG Recent Developments
Table 98. Santen Pharmaceutical Co. Ltd. Company Details
Table 99. Santen Pharmaceutical Co. Ltd. Business Overview
Table 100. Santen Pharmaceutical Co. Ltd. Diabetes Associated Ophthalmic Treatment Product
Table 101. Santen Pharmaceutical Co. Ltd. Revenue in Diabetes Associated Ophthalmic Treatment Business (2017-2022) & (US$ Million)
Table 102. Santen Pharmaceutical Co. Ltd. Recent Developments
Table 103. Novartis AG Company Details
Table 104. Novartis AG Business Overview
Table 105. Novartis AG Diabetes Associated Ophthalmic Treatment Product
Table 106. Novartis AG Revenue in Diabetes Associated Ophthalmic Treatment Business (2017-2022) & (US$ Million)
Table 107. Novartis AG Recent Developments
Table 108. Pfizer, Inc. Company Details
Table 109. Pfizer, Inc. Business Overview
Table 110. Pfizer, Inc. Diabetes Associated Ophthalmic Treatment Product
Table 111. Pfizer, Inc. Revenue in Diabetes Associated Ophthalmic Treatment Business (2017-2022) & (US$ Million)
Table 112. Pfizer, Inc. Recent Developments
Table 113. Genentech, Inc. Company Details
Table 114. Genentech, Inc. Business Overview
Table 115. Genentech, Inc. Diabetes Associated Ophthalmic Treatment Product
Table 116. Genentech, Inc. Revenue in Diabetes Associated Ophthalmic Treatment Business (2017-2022) & (US$ Million)
Table 117. Genentech, Inc. Recent Developments
Table 118. Carl Zeiss Meditec Company Details
Table 119. Carl Zeiss Meditec Business Overview
Table 120. Carl Zeiss Meditec Diabetes Associated Ophthalmic Treatment Product
Table 121. Carl Zeiss Meditec Revenue in Diabetes Associated Ophthalmic Treatment Business (2017-2022) & (US$ Million)
Table 122. Carl Zeiss Meditec Recent Developments
Table 123. Lumenis Company Details
Table 124. Lumenis Business Overview
Table 125. Lumenis Diabetes Associated Ophthalmic Treatment Product
Table 126. Lumenis Revenue in Diabetes Associated Ophthalmic Treatment Business (2017-2022) & (US$ Million)
Table 127. Lumenis Recent Developments
Table 128. Ellex Medical Lasers Ltd. Company Details
Table 129. Ellex Medical Lasers Ltd. Business Overview
Table 130. Ellex Medical Lasers Ltd. Diabetes Associated Ophthalmic Treatment Product
Table 131. Ellex Medical Lasers Ltd. Revenue in Diabetes Associated Ophthalmic Treatment Business (2017-2022) & (US$ Million)
Table 132. Ellex Medical Lasers Ltd. Recent Developments
Table 133. IRIDEX Corp. Company Details
Table 134. IRIDEX Corp. Business Overview
Table 135. IRIDEX Corp. Diabetes Associated Ophthalmic Treatment Product
Table 136. IRIDEX Corp. Revenue in Diabetes Associated Ophthalmic Treatment Business (2017-2022) & (US$ Million)
Table 137. IRIDEX Corp. Recent Developments
Table 138. Topcon Corp. Company Details
Table 139. Topcon Corp. Business Overview
Table 140. Topcon Corp. Diabetes Associated Ophthalmic Treatment Product
Table 141. Topcon Corp. Revenue in Diabetes Associated Ophthalmic Treatment Business (2017-2022) & (US$ Million)
Table 142. Topcon Corp. Recent Developments
Table 143. Abbott Medical Optics Company Details
Table 144. Abbott Medical Optics Business Overview
Table 145. Abbott Medical Optics Diabetes Associated Ophthalmic Treatment Product
Table 146. Abbott Medical Optics Revenue in Diabetes Associated Ophthalmic Treatment Business (2017-2022) & (US$ Million)
Table 147. Abbott Medical Optics Recent Developments
Table 148. Quantel Company Details
Table 149. Quantel Business Overview
Table 150. Quantel Diabetes Associated Ophthalmic Treatment Product
Table 151. Quantel Revenue in Diabetes Associated Ophthalmic Treatment Business (2017-2022) & (US$ Million)
Table 152. Quantel Recent Developments
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diabetes Associated Ophthalmic Treatment Market Share by Type: 2021 VS 2028
Figure 2. Dry Eye Syndrome Features
Figure 3. Glaucoma Features
Figure 4. Eye Allergy & Infection Features
Figure 5. Diabetic Retinopathy Features
Figure 6. Diabetic associated Macular Degeneration Features
Figure 7. Uveitis Features
Figure 8. Cataract Features
Figure 9. Diabetic Macular Edema Features
Figure 10. Others Features
Figure 11. Global Diabetes Associated Ophthalmic Treatment Market Share by End User: 2021 VS 2028
Figure 12. Hospitals Case Studies
Figure 13. Ophthalmic Centers Case Studies
Figure 14. Ambulatory Surgical Centers Case Studies
Figure 15. Others Case Studies
Figure 16. Diabetes Associated Ophthalmic Treatment Report Years Considered
Figure 17. Global Diabetes Associated Ophthalmic Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 18. Global Diabetes Associated Ophthalmic Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 19. Global Diabetes Associated Ophthalmic Treatment Market Share by Region: 2021 VS 2028
Figure 20. Global Diabetes Associated Ophthalmic Treatment Market Share by Players in 2021
Figure 21. Global Top Diabetes Associated Ophthalmic Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Associated Ophthalmic Treatment as of 2021)
Figure 22. The Top 10 and 5 Players Market Share by Diabetes Associated Ophthalmic Treatment Revenue in 2021
Figure 23. North America Diabetes Associated Ophthalmic Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 24. North America Diabetes Associated Ophthalmic Treatment Market Size Market Share by Type (2017-2028)
Figure 25. North America Diabetes Associated Ophthalmic Treatment Market Size Market Share by End User (2017-2028)
Figure 26. North America Diabetes Associated Ophthalmic Treatment Market Size Share by Country (2017-2028)
Figure 27. United States Diabetes Associated Ophthalmic Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Canada Diabetes Associated Ophthalmic Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Europe Diabetes Associated Ophthalmic Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 30. Europe Diabetes Associated Ophthalmic Treatment Market Size Market Share by Type (2017-2028)
Figure 31. Europe Diabetes Associated Ophthalmic Treatment Market Size Market Share by End User (2017-2028)
Figure 32. Europe Diabetes Associated Ophthalmic Treatment Market Size Share by Country (2017-2028)
Figure 33. Germany Diabetes Associated Ophthalmic Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. France Diabetes Associated Ophthalmic Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. U.K. Diabetes Associated Ophthalmic Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Italy Diabetes Associated Ophthalmic Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Russia Diabetes Associated Ophthalmic Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Nordic Countries Diabetes Associated Ophthalmic Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Asia-Pacific Diabetes Associated Ophthalmic Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 40. Asia Pacific Diabetes Associated Ophthalmic Treatment Market Size Market Share by Type (2017-2028)
Figure 41. Asia Pacific Diabetes Associated Ophthalmic Treatment Market Size Market Share by End User (2017-2028)
Figure 42. Asia Pacific Diabetes Associated Ophthalmic Treatment Market Size Share by Region (2017-2028)
Figure 43. China Diabetes Associated Ophthalmic Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Japan Diabetes Associated Ophthalmic Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. South Korea Diabetes Associated Ophthalmic Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Southeast Asia Diabetes Associated Ophthalmic Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. India Diabetes Associated Ophthalmic Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Australia Diabetes Associated Ophthalmic Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 49. Latin America Diabetes Associated Ophthalmic Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Latin America Diabetes Associated Ophthalmic Treatment Market Size Market Share by Type (2017-2028)
Figure 51. Latin America Diabetes Associated Ophthalmic Treatment Market Size Market Share by End User (2017-2028)
Figure 52. Latin America Diabetes Associated Ophthalmic Treatment Market Size Share by Country (2017-2028)
Figure 53. Mexico Diabetes Associated Ophthalmic Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Brazil Diabetes Associated Ophthalmic Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Middle East & Africa Diabetes Associated Ophthalmic Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 56. Middle East and Africa Diabetes Associated Ophthalmic Treatment Market Size Market Share by Type (2017-2028)
Figure 57. Middle East and Africa Diabetes Associated Ophthalmic Treatment Market Size Market Share by End User (2017-2028)
Figure 58. Middle East and Africa Diabetes Associated Ophthalmic Treatment Market Size Share by Country (2017-2028)
Figure 59. Turkey Diabetes Associated Ophthalmic Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 60. Saudi Arabia Diabetes Associated Ophthalmic Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 61. UAE Diabetes Associated Ophthalmic Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 62. Alcon Revenue Growth Rate in Diabetes Associated Ophthalmic Treatment Business (2017-2022)
Figure 63. Johnson & Johnson Services, Inc. Revenue Growth Rate in Diabetes Associated Ophthalmic Treatment Business (2017-2022)
Figure 64. Bausch Health Revenue Growth Rate in Diabetes Associated Ophthalmic Treatment Business (2017-2022)
Figure 65. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Diabetes Associated Ophthalmic Treatment Business (2017-2022)
Figure 66. Allergan Revenue Growth Rate in Diabetes Associated Ophthalmic Treatment Business (2017-2022)
Figure 67. Bayer AG Revenue Growth Rate in Diabetes Associated Ophthalmic Treatment Business (2017-2022)
Figure 68. Santen Pharmaceutical Co. Ltd. Revenue Growth Rate in Diabetes Associated Ophthalmic Treatment Business (2017-2022)
Figure 69. Novartis AG Revenue Growth Rate in Diabetes Associated Ophthalmic Treatment Business (2017-2022)
Figure 70. Pfizer, Inc. Revenue Growth Rate in Diabetes Associated Ophthalmic Treatment Business (2017-2022)
Figure 71. Genentech, Inc. Revenue Growth Rate in Diabetes Associated Ophthalmic Treatment Business (2017-2022)
Figure 72. Carl Zeiss Meditec Revenue Growth Rate in Diabetes Associated Ophthalmic Treatment Business (2017-2022)
Figure 73. Lumenis Revenue Growth Rate in Diabetes Associated Ophthalmic Treatment Business (2017-2022)
Figure 74. Ellex Medical Lasers Ltd. Revenue Growth Rate in Diabetes Associated Ophthalmic Treatment Business (2017-2022)
Figure 75. IRIDEX Corp. Revenue Growth Rate in Diabetes Associated Ophthalmic Treatment Business (2017-2022)
Figure 76. Topcon Corp. Revenue Growth Rate in Diabetes Associated Ophthalmic Treatment Business (2017-2022)
Figure 77. Abbott Medical Optics Revenue Growth Rate in Diabetes Associated Ophthalmic Treatment Business (2017-2022)
Figure 78. Quantel Revenue Growth Rate in Diabetes Associated Ophthalmic Treatment Business (2017-2022)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed

---